Thereafter, using patient matched samples, a sequential loss of ST6GAL1 could be demonstrated throughout the course of bladder cancer development beginning in the CIS stage and continuing to invasive disease when compared with the corresponding normal urothelium. This evidence concerns the gene ST6GAL1 and urinary bladder cancer.